Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
1.090
+0.020 (1.87%)
Jun 2, 2026, 4:00 PM EDT - Market closed
Bio Green Med Solution Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.34 | 3.51 | 3.14 | 3.38 | 18.35 | 36.56 |
Cash & Short-Term Investments | 3.34 | 3.51 | 3.14 | 3.38 | 18.35 | 36.56 |
Cash Growth | 463.02% | 11.73% | -7.13% | -81.59% | -49.82% | 9.44% |
Accounts Receivable | 1.19 | 1.26 | - | - | - | - |
Inventory | 0.95 | 1.38 | - | - | - | - |
Other Current Assets | 0.15 | 0.11 | 0.54 | 4.07 | 6.07 | 4.38 |
Total Current Assets | 5.62 | 6.26 | 3.67 | 7.44 | 24.41 | 40.94 |
Net Property, Plant & Equipment | 0.15 | 0.15 | 0.01 | 0.1 | 0.17 | 0.09 |
Goodwill | 1.57 | 1.57 | - | - | - | - |
Other Long-Term Assets | 0.22 | 0.21 | 0.41 | 1.26 | 3.47 | 2.1 |
Total Assets | 7.56 | 8.19 | 4.09 | 8.81 | 28.05 | 43.14 |
Accounts Payable | 0.26 | 0.62 | 4.6 | 3.54 | 2.56 | 2.12 |
Accrued Expenses | 0.54 | 0.72 | 1.67 | 4.62 | 4.95 | 3.3 |
Total Current Liabilities | 0.8 | 1.33 | 6.27 | 8.16 | 7.51 | 5.41 |
Long-Term Leases | - | 0 | - | 0.04 | 0.11 | 0.03 |
Other Long-Term Liabilities | 0.01 | 0.01 | - | - | - | - |
Total Long-Term Liabilities | 0.01 | 0.01 | - | 0.04 | 0.11 | 0.03 |
Total Liabilities | 0.8 | 1.34 | 6.27 | 8.2 | 7.62 | 5.44 |
Common Stock | 0.01 | 0.01 | - | - | 0 | 0.01 |
Additional Paid-in Capital | 461.39 | 461.29 | 438.21 | 429.8 | 422.98 | 422.96 |
Accumulated Other Comprehensive Income | -0.03 | -0.04 | -0.89 | -0.91 | -1.32 | -0.75 |
Retained Earnings | -454.61 | -454.41 | -439.49 | -428.28 | -405.73 | -384.53 |
Total Common Shareholders' Equity | 6.76 | 6.84 | -2.17 | 0.61 | 15.94 | 37.69 |
Minority Interest | - | - | - | - | 4.49 | - |
Shareholders' Equity | 6.76 | 6.84 | -2.17 | 0.61 | 20.43 | 37.69 |
Total Liabilities & Equity | 7.56 | 8.19 | 4.09 | 8.81 | 28.05 | 43.14 |
Total Debt | - | 0 | 0 | 0.04 | 0.11 | 0.03 |
Net Cash (Debt) | 3.34 | 3.5 | 3.14 | 3.34 | 18.24 | 36.53 |
Net Cash Growth | -4.68% | 11.67% | -6.11% | -81.68% | -50.07% | 12.92% |
Net Cash Per Share | 0.01 | 1.60 | 140.58 | 942.45 | 388.90 | 982.16 |
Book Value | 6.76 | 6.84 | -2.17 | 0.61 | 15.94 | 37.69 |
Book Value Per Share | 0.01 | 3.13 | -97.43 | 171.23 | 339.86 | 1013.46 |
Tangible Book Value | 5.19 | 5.27 | -2.17 | 0.61 | 15.94 | 37.69 |
Tangible Book Value Per Share | 0.01 | 2.41 | -97.43 | 171.23 | 339.86 | 1013.46 |